During the past decade, Clinical Research Alliance conducted 53 clinical trials. In the 10-year time frame, 53 clinical trials started and 38 clinical trials were completed, i.e. on average, 71.7% percent of trials that started reached the finish line to date. In the past 5 years, 21 clinical trials started and 24 clinical trials were completed. i.e. 114.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Clinical Research Alliance" #1 sponsor was "Novartis Pharmaceuticals" with 10 trials, followed by "BeiGene" with 7 trials sponsored, "Incyte Corporation" with 7 trials sponsored, "Celgene" with 6 trials sponsored and "Hoffmann-La Roche" with 6 trials sponsored. Other sponsors include 34 different institutions and companies that sponsored additional 33 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Clinical Research Alliance" #1 collaborator was "ARMO BioSciences" with 2 trials as a collaborator, "Eli Lilly and Company" with 2 trials as a collaborator, "Amgen" with 1 trials as a collaborator, "EMD Serono" with 1 trials as a collaborator and "Gilead Sciences" with 1 trials as a collaborator. Other collaborators include 0 different institutions and companies that were collaborators in the rest 10 trials.

According to Clinical.Site data, the most researched conditions in "Clinical Research Alliance" are "Lymphoma" (6 trials), "Multiple Myeloma" (6 trials), "Chronic Lymphocytic Leukemia" (5 trials), "Breast Cancer" (4 trials) and "Marginal Zone Lymphoma" (4 trials). Many other conditions were trialed in "Clinical Research Alliance" in a lesser frequency.

Most popular intervention types in "Clinical Research Alliance" are "Drug" (74 trials), "Biological" (3 trials), "Other" (3 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Carboplatin" (6 trials), "Docetaxel" (6 trials), "Dexamethasone" (5 trials), "Gemcitabine" (5 trials) and "Parsaclisib" (5 trials). Other intervention names were less common.

The vast majority of trials in "Clinical Research Alliance" are 65 trials for "All" genders, 7 trials for "Female" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "Clinical Research Alliance". undefined are not yet recruiting, 13 are recruiting, 18 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 33 completed trials in Clinical Research Alliance, undefined suspended trials, and 8 terminated clinical trials to date.

Out of the total trials that were conducted in Clinical Research Alliance, 15 "Phase 1" clinical trials were conducted, 34 "Phase 2" clinical trials and 29 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 0 trials that are defined as “Not Applicable".